Ngā hua rapu - Jules Hernández‐Sánchez
- E whakaatu ana i te 1 - 5 hua o te 5
-
1
-
2
Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi. mā Reynaldo Dietze, Sandra Carvalho, Luiz Carlos Pedrosa Valli, J D Berman, Thomas G. Brewer, Wilbur K. Milhous, Jules Hernandez-Sanchez, Brian G. Schuster, Max Grögl
I whakaputaina 2001Artigo -
3
Clinical trial protocol for TRANSFORM‐UK: A therapeutic open‐label study of tocilizumab in the treatment of pulmonary arterial hypertension mā Jules Hernández‐Sánchez, Louise Harlow, Colin Church, Seán Gaine, Emily Knightbridge, Katherine Bunclark, Dee Gor, Alun Bedding, Nicholas W. Morrell, Paul A. Corris, Mark Toshner
I whakaputaina 2017Artigo -
4
Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension mā Mark Toshner, Colin Church, Lars Harbaum, Christopher J. Rhodes, Sofia S. Villar Moreschi, James Liley, R. Jones, Amit Arora, Ken Batai, Ankit A. Desai, Gerry Coghlan, J. Simon R. Gibbs, Dee Gor, Stefan Gräf, Louise Harlow, Jules Hernández‐Sánchez, Luke Howard, Marc Humbert, Jason H. Karnes, David G. Kiely, Rick A. Kittles, Emily Knightbridge, Brian Lam, Katie A. Lutz, William C. Nichols, Michael W. Pauciulo, Joanna Pepke‐Żaba, Jay Suntharalingam, Florent Soubrier, Richard C. Trembath, Tae‐Hwi Schwantes‐An, Stephen J. Wort, Martin R. Wilkins, Seán Gaine, Nicholas W. Morrell, Paul A. Corris
I whakaputaina 2021Artigo -
5
Phenotypic Characterization of <i>EIF2AK4</i> Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension mā Charaka Hadinnapola, Marta Bleda, Matthias Haimel, Nicholas Screaton, Andrew J. Swift, Peter Dorfmüller, Stephen Preston, Mark Southwood, Jules Hernández‐Sánchez, Jennifer M. Martin, Carmen Treacy, Katherine Yates, Harm Jan Bogaard, Colin Church, Gerry Coghlan, Robin Condliffe, Paul A. Corris, Simon Gibbs, Barbara Girerd, Simon Holden, Marc Humbert, David G. Kiely, Allan Lawrie, Rajiv D. Machado, Robert Ross, Shahin Moledina, David Montani, Michael Newnham, Andrew J. Peacock, Joanna Pepke‐Żaba, Paula Rayner-Matthews, Olga Shamardina, Florent Soubrier, Laura Southgate, Jay Suntharalingam, Mark Toshner, Richard C. Trembath, Anton Vonk Noordegraaf, Martin R. Wilkins, Stephen J. Wort, John Wharton, Stefan Gräf, Nicholas W. Morrell, Timothy J. Aitman, David Bennett, Mark J. Caulfield, Patrick F. Chinnery, Daniel P. Gale, Ania Koziell, Taco W. Kuijpers, Michael Laffan, Eamonn R. Maher, Hugh S. Markus, Willem H. Ouwehand, David J. Perry, F. Lucy Raymond, Irene Roberts, Kenneth G. C. Smith, Adrian J. Thrasher, Hugh Watkins, Catherine Williamson, Geoffrey Woods, Sofie Ashford, John R. Bradley, Debra Fletcher, Tracey Hammerton, Roger James, Nathalie Kingston, Willem H. Ouwehand, Christopher J. Penkett, F. Lucy Raymond, Kathleen Stirrups, Marijke Veltman, Timothy M. Young, Sofie Ashford, Matthew A. Brown, Emma Clement, John Davis, Eleanor Dewhurst, Marie Erwood, Amy Frary, Rachel Linger, Sofia Papadia, Karola Rehnström, Hannah Stark, David Allsup, Steve Austin, Tamam Bakchoul, Tadbir K. Bariana, Paula Bolton‐Maggs, Elizabeth Chalmers, Peter Collins, Wendy N. Erber, Tamara Everington, Rémi Favier, Kathleen Freson, Bruce Furie, Michael Gattens, Keith Gomez, Daniel Greene
I whakaputaina 2017Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Internal medicine
Medicine
Biology
Gene
Genetics
Immunology
Inflammation
Interleukin 6
Pulmonary hypertension
Tocilizumab
ACVRL1
Adverse effect
Allele
Ambrisentan
BMPR2
Bone morphogenetic protein
Bosentan
CD34
Candidate gene
Cardiology
Chloroquine
Cohort
Compound heterozygosity
Computer science
Demography
Disease
Dosing
Endoglin
Endothelin receptor
Gastroenterology